Cargando…
Basic and clinical immunology – 3025. Suppression of eosinphil activation by levocetirizine hydrochloride in vivo
Autores principales: | Kawaguchi, Kenichiro, Kanai, Kenichi, Asano, Kazuhito, Sanbe, Takeyuki, Suzaki, Harumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643506/ http://dx.doi.org/10.1186/1939-4551-6-S1-P201 |
Ejemplares similares
-
Basic and clinical immunology – 3023. Influence of fexofenadine hydrochloride on uteroglobin production from nasal epithelial cells in vitro and in vivo
por: Kanai, Kenichi, et al.
Publicado: (2013) -
Basic and clinical immunology – 3021. Inhibitory action of levocetirzine hydrochloride on eosinophil actication in vitro
por: Furuta, Atsuko, et al.
Publicado: (2013) -
Basic and clinical immunology – 3022. Inhibitory action of fexofenadine hydrochloride on mast cell activation in vitro
por: Suzuki, Miyuki, et al.
Publicado: (2013) -
Suppression of Osteopontin Functions by Levocetirizine, a Histamine H(1) Receptor Antagonist, In Vitro
por: Komatsuzaki, Toshimitsu, et al.
Publicado: (2013) -
Suppression of Matrix Metalloproteinase Production in Nasal
Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
por: Shimizu, Toshiyuki, et al.
Publicado: (2005)